tm logo

Monitor this mark

View On USPTO

BIPAZEN
Live/Registered
REGISTERED

on 30 Apr 2024

Last Applicant/ Owned by

KVR Pharmaceuticals Inc.

11 Millbank Avenue

Toronto, Ontario

CA

M5P1S2

Serial Number

88771717 filed on 24th Jan 2020

Registration Number

7369992 registered on 30th Apr 2024

in the Principal Register

Correspondent Address

Eugene J. Rath III

Eugene J. Rath III FLYNN THIEL, P.C.

KALAMAZOO, MI 49008-1631

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

BIPAZEN

Pharmaceutical preparations and substances for the treatment of metabolic, hemorrhagic, endocrine, genitourinary, oncological, hepatological and hormonal related diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the treatment of metabolic, hemorrhagic, endocrine, genitourinary, oncological, hepatological and hormonal related diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 88771717

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2653.T0001US

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
30th Apr 2024REGISTERED-PRINCIPAL REGISTER
30th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th Feb 2024PUBLISHED FOR OPPOSITION
24th Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11th Jan 2024APPROVED FOR PUB - PRINCIPAL REGISTER
10th Jan 2024TEAS/EMAIL CORRESPONDENCE ENTERED
10th Jan 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
08th Jan 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30th Nov 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED